HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Iñigo Sáenz de Tejada Selected Research

AC3056

2/2009The novel antioxidant, AC3056 (2,6-di-t-butyl-4-((dimethyl-4-methoxyphenylsilyl)methyloxy)phenol), reverses erectile dysfunction in diabetic rats and improves NO-mediated responses in penile tissue from diabetic men.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Iñigo Sáenz de Tejada Research Topics

Disease

2Erectile Dysfunction
02/2009 - 11/2006
1Pathologic Processes
09/2011
1Hypersensitivity (Allergy)
11/2006

Drug/Important Bio-Agent (IBA)

1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2011
1AC3056IBA
02/2009
1AntioxidantsIBA
02/2009
1bisindolylmaleimide IIBA
11/2006
1Protein Kinase CIBA
11/2006
115-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidIBA
11/2006